Bicycle Therapeutics stock sinks following cancer datanews2024-12-13T19:49:09+00:00December 13th, 2024|Endpoints News|
EMA’s committee says expanded label for Lilly’s Mounjaro into sleep apnea not necessarynews2024-12-13T17:40:54+00:00December 13th, 2024|Endpoints News|
SABCS Roundup: BeiGene and Pfizer CDK4 inhibitors, ALX’s CD47news2024-12-13T15:57:04+00:00December 13th, 2024|Endpoints News|
AbbVie makes another small I&I acquisition, buying Nimble for $200Mnews2024-12-13T14:41:24+00:00December 13th, 2024|Endpoints News|
FDA adcomm reviews safety signals from pediatric RSV trialsnews2024-12-12T20:56:22+00:00December 12th, 2024|Endpoints News|
‘Serious liver injury’ cases on Ocaliva lead FDA to call for monitoringnews2024-12-12T20:20:12+00:00December 12th, 2024|Endpoints News|
‘Unsupported’ drug price increases add to US costs, ICER claimsnews2024-12-12T16:22:52+00:00December 12th, 2024|Endpoints News|
Padlock shareholders sue Bristol Myers over milestone dispute after 2016 acquisitionnews2024-12-12T16:20:04+00:00December 12th, 2024|Endpoints News|
Lilly to study obesity drugs in addiction, and is considering cognitive disordersnews2024-12-11T20:52:55+00:00December 11th, 2024|Endpoints News|
RFK Jr. lobbied against vaccine EUAs. At HHS, he could undo themnews2024-12-11T20:09:11+00:00December 11th, 2024|Endpoints News|
